Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00973518 · ClinicalTrials.gov registry record

Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)

A clinical trial, sponsored by Orasi Medical.

Completed
Registry status
160
Enrollment target

NCT00973518: Completed study, sponsored by Orasi Medical.

NCT00973518 is a clinical trial that has completed, run by Orasi Medical. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00973518 has completed, sponsored by Orasi Medical.

COMPLETED
Registry status
160 participants
Enrollment target

Study Summary

The current study is intended to enrich and extend the database of Alzheimer's Disease (AD) and healthy control (HC) MEG scans and will include patients meeting DSM-IV-TR criteria for dementia of Alzheimer's type, and age- and gender-matched HC subjects meeting criteria of normal neurological function. This study will include 2 MEG and electroencephalography (EEG) scans on approximately 80 AD subjects and 80 HC subjects over approximately 30 days. All subjects will have MEG/EEG scans at baseline and 28 - 35 days after baseline. Within one day of each scan visit AD subjects will undergo 4 standard functional tests while HC subjects will undergo 2 standard functional tests. This study will test the following hypotheses: * MEG scans of resting-state, eyes-open brain function reveal patterns of correlated activity that differ between HC subjects and subjects diagnosed with dementia of Alzheimer's type; * Patterns of correlated activity measured in AD subjects correspond to other measures of disease severity such as standard functional test scores; * MEG scan patterns for HC subjects are consistent across repeated measures taken over a 30 day period.

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2009-09
Est. Completion 2010-06
Orasi Medical

3 total trials

What the finished NCT00973518 record still lists

NCT00973518 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00973518 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00973518 about?

NCT00973518 is a clinical study titled "Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)". The current study is intended to enrich and extend the database of Alzheimer's Disease (AD) and healthy control (HC) MEG scans and will include patients meeting DSM-IV-TR criteria for dementia of Alzheimer's type, and age- and gender-matched HC subjects meeting criteria of normal neurological functi...

What is the current status of trial NCT00973518?

This trial is currently completed. The enrollment target is 160 participants. The study started on 2009-09. Estimated completion is 2010-06.

Who is sponsoring clinical trial NCT00973518?

This trial is sponsored by Orasi Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00973518, the US trial registry maintained by the National Library of Medicine. NCT00973518 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.